Clinical Trial Update: Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design

View source ↗

Summary

A pilot crossover study evaluating disease stability in Relapsing Remitting Multiple Sclerosis by switching between natalizumab and dimethyl fumarate has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)
• Tysabri (Natalizumab)

Snippet

Sponsor: Rocky Mountain MS Research Group, LLC | Conditions: Relapsing Remitting Multiple Sclerosis | Status: COMPLETED